BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
Public ClinicalTrials.gov record NCT01903265. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Study identification
- NCT ID
- NCT01903265
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Tonix Pharmaceuticals, Inc.
- Industry
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- TNX-102 SL 2.8mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2013
- Primary completion
- Jun 30, 2014
- Completion
- Aug 31, 2014
- Last update posted
- Dec 22, 2016
2013 – 2014
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 107 Scripps Drive | Sacramento | California | 95825 | — |
| Radiant Research, Inc. | Denver | Colorado | 80239 | — |
| 16176 Cortez Boulevard | Brooksville | Florida | 34601 | — |
| 100 West Gore Street | Orlando | Florida | 32806 | — |
| 3401 North Central Avenue | Chicago | Illinois | 60634 | — |
| 71 Thomas Johnson Drive | Frederick | Maryland | 21702 | — |
| 370 Faunce Corner Road | North Dartmouth | Massachusetts | 02747 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| CRC of Jackson, LLC | Jackson | Mississippi | 39202 | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45219 | — |
| 1275 Olentangy River Road | Columbus | Ohio | 43212 | — |
| 18660 Bagley Road | Middleburg Heights | Ohio | 44130 | — |
| 1001 South Market Street | Mechanicsburg | Pennsylvania | 17055 | — |
| 322 Memorial Drive | Greer | South Carolina | 29650 | — |
| 1002 E. South Temple | Salt Lake City | Utah | 84102 | — |
| 1951 152nd Place NE | Bellevue | Washington | 98007 | — |
| 601 Broadway | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01903265, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2016 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01903265 live on ClinicalTrials.gov.